Spelling suggestions: "subject:"prague dawley rats"" "subject:"prague dawley cats""
21 |
Administration d'Eugénol intrathécal pour le traitement de la douleur neuropathiqueLionnet, Ludivine 08 1900 (has links)
Le projet porte sur l’étude de l’effet de l’eugénol, composant principal du clou de
girofle, sur la douleur neuropathique. L’objectif principal du projet était de
déterminer la contribution du système nerveux central dans l’effet analgésique de
l’eugénol. Lors d’une étude préliminaire, la pénétrabilité de l’eugénol a été
évaluée dans le système nerveux central du rat. Des échantillons de sang, de
cerveau et de moelle épinière ont été prélevés et les concentrations d’eugénol dans
ces différents tissus ont été analysées à l’aide d’un spectromètre de masse. Les
résultats ont montré que l’eugénol pénètre bien le système nerveux central avec
une distribution plus importante dans la moelle épinière. Après l’induction de la
douleur neuropathique à des rats Sprague-Dawley par le modèle de ligatures du
nerf sciatique, des injections intrathécales d’eugénol furent réalisées afin d’évaluer
l’effet central de l’eugénol. La plus forte dose d’eugénol a atténué l’allodynie
secondaire après 15min, 2h et 4h et a aussi amélioré l’hyperalgésie thermique
après 2h et 4h.
Ces résultats confirment l’hypothèse que l’eugénol atténue les deux aspects de la
douleur neuropathique que sont l’allodynie et l’hyperalgésie. Les injections au
niveau lombaire permettent de penser que l’eugénol, un agoniste/antagoniste des
récepteurs vanilloïdes pourrait diminuer la douleur neuropathique en agissant
notamment au niveau des récepteurs vanilloïdes situés dans la corne dorsale de la
moelle épinière. / The project is based on the study of the effects of eugenol, the main component of
clove oil, on neuropathic pain. The main objective was to determine the central
effect of eugenol. In a preliminary study we evaluated the penetrability of eugenol
in the central nervous system of rats. Blood, brain and spinal cord samples were
collected and concentrations were determined by mass spectrometry. Brain-toplasma
and spinal cord-to-plasma ratios suggest that eugenol penetrates the central
nervous system of rats relatively well, with a preferential distribution in the spinal
cord. Following the induction of neuropathic pain in male Sprague-Dawley rats
using the sciatic nerve ligation model, intrathecal injections of eugenol were done
to evaluate the central effect of eugenol. Treatment with the high dose of eugenol
significantly decreased secondary mechanical allodynia measured by the Von Frey
test after 15min, 2h and 4h and improved thermal hyperalgesia measured by the
Hargreaves device after 2h and 4h.
Results support the hypothesis that eugenol may alleviate neuropathic pain, both
allodynia and hyperalgesia. Eugenol, a vanilloid agonist/antagonist may therefore
reduce neuropathic pain by acting on vanilloid receptors at the level of the dorsal
horn of the spinal cord.
|
22 |
Modelo experimental para indução de esteatose hepática e esteatohepatite: estudo em ratos / Experimental model for induction of steatosis and steatohepatitis - study in ratsEliana Pinheiro da Silva 29 October 2012 (has links)
Introdução: A Doença Hepática Gordurosa Não Alcoólica (DHGNA) tem sido considerada atualmente a forma mais comum de doença hepática no mundo ocidental, relacionada principalmente ao aumento da prevalência da obesidade.A DHGNA abrange um largo espectro de doença, desde casos de esteatose simples (EH) até esteato-hepatite não alcoólica (EHNA) e fibrose, podendo evoluir para cirrose e carcinoma hepatocelular (CHC). Embora se conheçam os fatores predisponentes para o desenvolvimento de EHNA, sua patogênese, assim como tratamento eficaz, permanecem pouco conhecidos.Os lípides, principalmente gorduras neutras, fosfolipídios e colesterol, são componentes fundamentais das células, assim como as proteínas e os hidratos de carbono. Embora aumentos marcantes de proteínas e hidratos de carbono não produzam quaisquer alterações macroscópicas no fígado, um acúmulo de gordura é prontamente reconhecido pela coloração amarelada e pelo aumento de volume do órgão. Várias dietas tem sido usadas em animais de laboratórios, principalmente camundongos e ratos no sentido de induzir esteatose, esteatohepatite e fibrose hepática, embora nenhuma delas consiga reproduzir na totalidade os componentes essenciais da doença humana. Não encontramos em nenhum trabalho da literatura a utilização da dieta deficiente em colina e hiperlipídica (DCH), por nós utilizada. Objetivo: O objetivo deste estudo foi avaliar o efeito de uma dieta deficiente em colina e hiperlipídica (DCH) para desenvolver esteatose hepática, esteatohepatite e fibrose hepática no rato. Métodos: A doença hepática foi induzida em ratos Sprague-Dawley machos pesando de 300 a 350 gramas, hospedados em gaiolas padrão e recebendo água à vontade. Foi usado dieta deficiente em colina e hiperlipídica (DCH). Os animais foram distribuídos por meio de tabela sequencial randomizada em dois grupos. No grupo 1 dez ratos receberam a dieta por 4 meses e no grupo 2 dez ratos receberam a dieta durante 8 meses. Após o tempo estipulado das dietas os animais foram anestesiados e sacrificados. Os fígados dos animais foram retirados, pesados e enviados para estudo histopatológico de acordo com os critérios estabelecidos por Kleiner. Os animais foram pesados no início do experimento e por ocasião do sacrifício. Resultados: o peso dos animais do grupo 1 (DCH - 4 meses) no início do experimento variou de 305 a 350 gramas com média de 329,9 gramas e no fim do experimento de 529 a 615 gramas com média de 579,2 gramas. O percentual de ganho de peso dos animais variou de 60 a 86,93% com média de 75,72%. O peso dos animais do grupo 2 (DCH - 8 meses) no início do experimento variou de 320 a 353 gramas com média de 339,4 gramas e no fim do experimento variou de 661,5 a 783 gramas com média de 705,6 gramas. O percentual do ganho de peso dos animais variou de 95,58 a 123,71% com média de 107,78%. O peso do fígado dos animais do grupo 1 no fim do experimento variou de 24,5 a 29,5 gramas. O percentual do peso do fígado em relação ao peso dos animais do grupo 1 variou de 4,16 a 5,54% com média de 4,75%. O peso do fígado dos animais do grupo 2 no fim do experimento variou de 31 gramas a 39 gramas com média de 33,8 gramas. O percentual do peso do fígado em relação ao peso dos animais do grupo 2 variou de 4,63% a 5,07%, com média de 4,78%. A análise histopatológica dos animais do grupo 1 demonstrou intensa balonização e esteatose microgoticular com inflamação lobular; o estadiamento de fibrose foi discreto nestes animais. O estudo histopatológico dos animais do grupo 2 revelou intensa esteatose microgoticular e balonização com inflamação lobular; alguns animais apresentaram esteatose macrogoticular. Os animais deste grupo 2 apresentaram fibrose com grande variação individual. Os animais de ambos os grupos experimentais desenvolveram esteatohepatite, pois apresentaram o índice de atividade da doença hepática gordurosa não alcoólica (NAS)>=5. A análise comparativa demonstrou não haver diferença estatística no valor do NAS entre os dois grupos experimentais. Em relação ao estadiamento da fibrose na esteatohepatite não alcoólica, os animais do grupo 2 apresentaram uma tendência de escores mais elevados do que os animais do grupo 1. No entanto não houve diferença estatística entre os grupos devido a grande variação individual (p=0,2755). Conclusões: A dieta DCH administrada durante 4 e 8 meses induziu nos ratos aumento considerável de peso corpóreo e do peso do fígado. Os animais do grupo 1 apresentaram intensa balonização, esteatose microgoticular e inflamação lobular com discreta fibrose hepática. Os animais do grupo 2 apresentaram intensa balonização, esteatose macro e microgoticular, inflamação lobular e maior grau de fibrose hepática, bem estabelecida com formação de colágeno e expansão fibrosa nos espaços vasculares. A dieta deficiente em colina e hiperlipídica (DCH) induziu no rato esteatose hepática e esteatohepatite com fibrose, servindo de modelo experimental para proporcionar melhor entendimento para procedimentos terapêuticos futuros desta importante patologia do fígado. / Introduction: Nonalcoholic Fatty Liver Disease (NAFLD) has currently been regarded as the most common form of liver disease in the western world, mainly related to the increased prevalence of obesity. NAFLD covers a broad spectrum of diseases, since cases of simple steatosis (HS) to steatohepatitis (EHNA) and fibrosis, and may evolve to cirrhosis and hepatocellular carcinoma (CHC). Although the predisposing factors for the development of EHNA are well established, there is little knowledge on its pathogenesis as well as the effective treatment options. Lipids, especially phospholipids, neutral fats and cholesterol, are fundamental cell components, as well as proteins and carbohydrates. Although striking increases of proteins and carbohydrates do not produce liver macroscopic changes, fat build up can be rapidly recognized by the yellow coloring and increased organ volume. Many diets have been used in laboratory animals, mainly rats although none of them can fully reproduce the fundamental components of the human disease. We could not find in the literature any study on the use of choline-deficient and hiperlipidic diet (CHD), used in the present study. Goal: The objective of this study was to evaluate the effect of a cholinedeficient and hiperlipidic diet (CHD) on the development of steatosis, steatohepatitis and hepatic fibrosis in rats. Methods: The liver disease was induced in male Sprague-Dawley rats, weighing from 300 to 350 grams, hosted in standard cages and receiving water ad libitum and fed with a choline-deficient and hiperlipidic diet (CHD). The experimental animals were distributed by means of a random sequential table in two groups. In Group 1 ten rats received the diet for four months and in Group 2 ten rats received the same diet for eight months. After these predetermined feeding time periods the animals were anesthetized and sacrificed. The animal livers were then removed, weighed and sent to histopathological study according to the criteria established by Kleiner. All the animals were weighed at the beginning of the experiment and by the time of the sacrifice. Results: The weight of Group 1 animals (4 months CHD) at the beginning of the experiment varied from 305 to 350 grams with an average of 329.9 grams and at the end of the experiment from 529 to 615 grams averaging 579.2 grams. The percentage of weight gain in animals of this group ranged from 60% to 86.93% with an average of 75.72%. The weight of Group 2 animals (8 months CHD) at the start of the experiment varied from 320 to 353 grams with an average of 339.4 grams and at the end of the experiment from the 661.5 to 783 g with an average of 705.6 grams. The percentage of weight gain in animals of this group varied from 95.58% to 123.71%, averaging 107.78%. The liver weight of Group 1 animals at the end of the experiment varied from 24.5 to 29.5 grams. The percentage of liver weight in relation to the animals\' weight, in Group 1, ranged from 4.16% to 5.54%, with an average of 4.75%. The liver weight of Group 2 animals at the end of the experiment varied from 31gramas to 39 grams, with an average of 33.8 gram. The percentage of liver weight in relation to the animals\' weight, in Group 2, ranged from 4.63% to 5.07%, with an average of 4.78%. Liver histopathological analysis in Group 1 animals showed marked ballooning degeneration and microgoticular steatosis with lobular inflammation; fibrosis staging was discreet in these animals. Liver histopathological study in animals of Group 2 showed an intense microgoticular steatosis and ballooning with lobular inflammation; some animals of this group presented macrogoticular steatosis. The amount of hepatic fibrosis in animals of this group was extremely variable. Animals of both experimental groups developed steatohepatitis, as they presented the activity index of nonalcoholic fatty liver disease (NAS) >= 5. Statistical analysis did not show a significant difference between the NAS values of the two experimental groups. Fibrosis staging analysis in non-alcoholic steatohepatitis showed a trend toward higher scores in animals of Group 2 as compared to Group 1 animals. However there was no statistical difference between the groups due to a large individual variation (p = 0.2755). Conclusions: CHD diet administered for four and eight months induced considerable increases in the rats\' body weight and liver weight. Animals in Group 1 showed intense liver ballooning, steatosis and lobular inflammation with discrete microgoticular fibrosis. Animals in Group 2 presented intense ballooning, steatosis macro and microgoticular, lobular inflammation and a higher degree of well-established hepatic fibrosis, with collagen formation with fibrotic expansion in vascular spaces. Choline-deficient and hiperlipidic diet (CHD) in the rat induced hepatic steatosis and steatohepatitis with fibrosis, representing an experimental model, which can provide a better knowledge for future therapeutic procedures of this important liver pathology.
|
23 |
Carcinogênese mamária experimental induzida pelo 7, 12, dimetilbenz (A) antraceno (DMBA) : caracterização histopatológica comparada e identificação imunoistoquímica de células-tronco neoplásicas (CTNs) / Breast cancer neoplastic stem cells histology compared Sprague Dawley rats 7, 12 dimetilbenz (A) antraceneSouza, Philipi Coutinho de, 1987- 22 August 2018 (has links)
Orientador: André Almeida Schenka / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-22T13:11:13Z (GMT). No. of bitstreams: 1
Souza_PhilipiCoutinhode_M.pdf: 7492039 bytes, checksum: 04ef7a018050c98ae0be37a7e79c79e7 (MD5)
Previous issue date: 2013 / Resumo: O câncer de mama é a neoplasia maligna mais prevalente e a principal causa de óbito entre mulheres, no mundo. A despeito de avanços substanciais no entendimento da biologia da doença, nos métodos de detecção precoce, e em sua farmacoterapia, a sobrevida geral não se modificou significantemente nas últimas décadas. Portanto, pode se dizer que um dos deveres primordiais das Universidades Públicas engajadas com pesquisa básica e aplicadas consiste em contribuir para o desenvolvimento de novas estratégias de tratamento sistêmico desta neoplasia. Nesse contexto, um dos alvos estratégicos mais promissores no desenvolvimento de novos fármacos antineoplásicos é representado pela célula-tronco neoplásica (CTN). As CTNs têm sido associadas em inúmeros estudos à capacidade de algumas neoplasias malignas de resistir às principais modalidades terapêuticas antineoplásicas, especialmente à: radio-, quimio-, hormônio- e imunoterapias. Em resumo, na atualidade, a detecção de CTNs constitui uma ferramenta clínica bastante promissora enquanto alvo terapêutico, fator prognóstico e preditivo de resposta terapêutica. O objetivo deste trabalho foi descrever e discutir as potencialidades e limitações do modelo de carcinogênese mamária pelo DMBA, após reclassificação das neoplasias mamárias segundo os critérios diagnósticos da OMS (2003, 2012), subtipagem molecular e quantificação de imunomarcadores prognósticos, preditivos e de CTN. Após a aplicação do protocolo experimental de indução química pelo DMBA e a eutanásia dos animais controle e experimental, suas linhas mamárias (contendo ou não tumores) foram ressecadas e avaliadas quanto à morfologia e a imunoexpressão para marcadores de CTNs. Após 13 semanas, 100% dos animais desenvolveram neoplasias macroscópicas e histologicamente compatíveis com os critérios de avaliação indicados pela OMS. Os tumores foram classificados em carcinoma ductal, carcinoma papilífero, carcinoma lobular, carcinoma mioepitelial e tumor filóide, sendo o tipo mais frequente, o ductal. Poucos marcadores imunoistoquímicos mostraram correlação com variáveis de comportamento biológico. Mesmo assim, o grau de correlação não foi elevado. A grande heterogeneidade morfológica intratumoral e interanimal, associada à presença de subtipos histológicos bifásicos (tumor filóide), tumores com diferenciação mioepitelial/basal e à grande positividade para marcadores CTN clássicos (tanto em termos de frequência na amostra como em termos de distribuição média nas neoplasias) demonstram a participação clara de CTNs no modelo, o que o torna um importante referencial como modelo in vivo para o teste de drogas anti-CTN específicas. O modelo reproduz os principais subtipos histológicos e moleculares de câncer mamário, o que significa que poderá ser utilizado no estudo pormenorizado de drogas indicadas especificamente para cada subcategoria molecular (e.g., agentes hormonais que são indicados especificamente para os tipos luminais e trastuzumab, indicado nos tumores do subtipo HER2), bem como no desenvolvimento de novas drogas com maior especificidade para a classe molecular de interesse / Abstract: Breast cancer is the most common malignancy and the leading cause of death from cancer among females worldwide. Despite all the research and all the progress, methods of early detection, and its pharmacotherapy, overall survival has not changed significantly in recent decades. Therefore, the Public University has been engaged in basic and applied research is too contributed to the development of new strategies for systemic treatment of this malignancy. In this context, one of the most promising strategic targets in the development of the anticancer drugs is represented by neoplastic stem cell (NSC). Neoplastic stem cell has been linked in various studies to the capacity of some malignancies to resist major antineoplastic therapeutic modalities, especially: radio-, chemo-, hormone- and immunotherapies. In summary, the detection of NSCs is a clinical tool very promising while therapeutic target and prognostic factor predictive of therapeutic response. The aim of this study was to describe and discuss the strengths and limitations of the model of mammary carcinogenesis by DMBA, after reclassification of breast cancer according to the diagnostic criteria of the WHO (2003, 2012), and quantification of molecular subtyping prognostic immunomarkers, predictive and NSC. After application of the experimental protocol of chemical induction by DMBA and euthanasia of experimental and control animals, the mammary lines (with or without tumors) were resected and evaluated the morphology and immunostaining for markers of NSCs. After 13 weeks, 100% of the animals developed macroscopic neoplasms and histologically consistent with the evaluation criteria of evaluation indicated by WHO. Tumors were classified as ductal carcinoma, papillary carcinoma, lobular carcinoma, myoepithelial carcinoma and phyllodes tumor, being the most common type, the ductal. Few immunohistochemical markers correlated with variable behavior biological. Nevertheless, the degree of correlation was not high. The morphological intratumoral heterogeneity and interanimal associated with the presence of histological biphasic subtypes (phyllodes tumor), tumors with myoepithelial/basal differentiation and the positivity for NSCs classic markers (both in terms of frequency in the sample and in terms of the average distribution neoplasias) demonstrate a clear involvement of NSCs in the model, making it an important reference as a model for in vivo testing of anti-specific NSC. The model reproduces the main molecular and histological subtypes of breast cancer, which means that could be used in detailed study drug indicated specifically for each subcategory molecular (eg, hormonal agents that are suitable specifically for the luminal type and trastuzumab indicated in tumors HER2 subtype), as well as to develop new drugs with higher specificity for the class of molecular interest / Mestrado / Farmacologia / Mestre em Farmacologia
|
24 |
Early life stress effects on neuroimmune function in limbic brain regions and mood-related behavior in male and female Sprague-Dawley ratsSaulsbery, Angela I. January 2019 (has links)
No description available.
|
25 |
Quantitation of a Novel Engineered Anti-infective Host Defense Peptide, ARV-1502: Pharmacokinetic Study of Different Doses in Rats and DogsBrakel, Alexandra, Volke, Daniela, Kraus, Carl N., Otvos, Laszlo, Hoffmann, Ralf 03 April 2023 (has links)
The designer proline-rich antimicrobial peptide (PrAMP) Chex1-Arg20 amide (ARV-1502)
is active against Gram-negative and Gram-positive pathogens in differentmurine infection
models when administered parenterally and possesses a wide therapeutic index. Here
we studied the pharmacokinetics of ARV-1502 for the first time when administered
intramuscularly or intravenously (IV) in Sprague Dawley rats and Beagle dogs. First, a
specific and robust quantitation method relying on parallel reaction monitoring (PRM)
using a high-resolution hybrid quadrupole-Orbitrap mass spectrometer coupled on-line
to reversed-phase uHPLC was established and validated. The limit of detection was
2 ng/mL and the limit of quantitation was 4 ng/mL when spiked to pooled rat and dog
plasma. When ARV-1502 was administered IV at doses of 75 and 250 μg/kg in dogs
and rats, the plasma concentrations were 0.7 and 3.4μg/mL 2min post-administration,
respectively. ARV-1502 plasma concentrations declined exponentially reaching levels
between 2 and 4 ng/mL after 2 h. Intramuscular administration of 0.75 mg/kg in dogs
and 2.5 mg/kg in rats resulted in a different pharmacokinetics profile. The plasma
concentrations peaked at 15min post-injection at 1μg/mL (dogs) and 12μg/mL (rats)
and decreased exponentially within 3 h to 4 and 16 ng/mL, respectively. The initial
plasma concentrations of ARV-1502 and the decay timing afterwards indicated that
the peptide circulated in the blood stream for several hours, at some point above the
minimal inhibitory concentration against multidrug-resistant Enterobacteriaceae, with
blood concentrations sufficient to suppress bacterial growth and to modulate the
immune system.
|
26 |
Caractérisation de la toxicocinétique de l’octylphénol chez le rat en vue d’une meilleure analyse de risque toxicologique des perturbateurs endocriniensHamelin, Geneviève 04 1900 (has links)
Le p-tert-octylphénol est un produit présent dans l’environnement et issu de la dégradation des alkylphénols éthoxylés. Ce composé a la capacité de se lier au récepteur œstrogénique et d’exercer ainsi un léger effet œstrogénique. Les objectifs de cette étude étaient de 1) développer une méthode d'identification de l'octylphénol dans le sang et les tissus à l'aide de la chromatographie en phase gazeuse jumelée à la spectrométrie de masse, 2) caractériser la toxicocinétique sanguine et tissulaire de l’octylphénol chez le rat Sprague-Dawley mâle et femelle et 3) développer un modèle toxicocinétique à base physiologique permettant de décrire la cinétique sanguine et tissulaire de l’octylphénol inchangé. Pour ce faire, des rats mâle et femelle Sprague-Dawley ont reçu des doses uniques d’octylphénol par les voies intraveineuse, orale et sous-cutanée. Deux autres groupes ont reçu des doses répétées d'octylphénol par voie orale pour une durée de 35 jours consécutifs pour les femelles ou 60 jours pour les mâles. Les concentrations sanguines et tissulaires d’octylphénol ont été mesurées à différents moments après administration à partir d’une méthode d’analyse développée dans nos laboratoires dans le cadre de ce projet. Les expériences impliquant des administrations uniques ont montré que les concentrations sanguines et tissulaires d'octylphénol étaient en général plus élevées chez les femelles que chez les mâles. Des expériences réalisées avec des microsomes hépatiques ont confirmé que ces différences étaient vraisemblablement reliées au métabolisme de l'octylphénol. Les expériences impliquant des administrations répétées ont montré qu'il n'y avait pas d'accumulation d'octylphénol dans l'organisme aux doses étudiées. Les résultats obtenus expérimentalement ont servi à développer et valider un modèle toxicocinétique à base physiologique. Ce modèle a permis de simuler adéquatement les concentrations sanguines et tissulaires d'octylphénol suite à des expositions intraveineuses, orales et sous-cutanées. En conclusion, cette étude a fourni des données essentielles sur la toxicocinétique de l'octylphénol. Ces données sont nécessaires pour établir la relation entre la dose externe et la dose interne et vont contribuer à une meilleure évaluation des risques liés à l'octylphénol. / p-tert-Octylphenol is a degradation product of alkylphenol ethoxylates that can be found in the environment. It has been reported to act as a weak estrogenic compound by binding to the estrogen receptor. This study was undertaken to 1) develop a sensitive method for the determination of octylphenol in blood and various tissues using gas chromatography coupled with detection by mass spectrometry, 2) characterize the blood and tissues toxicokinetics of octylphenol in male and female Sprague-Dawley rats and 3) develop a physiologically-based toxicokinetic model for octylphenol that can describe/predict unchanged blood and tissues octylphenol concentrations in rats. Male and female Sprague-Dawley rats were given a single dose of octylphenol either by oral gavage, intravenous injection or subcutaneous injection. In a repeated dosing experiment, rats were given octylphenol (oral) daily for 35 days (female) or 60 days (male). Blood and tissue samples were collected at various time following the onset of exposure and analyzed for octylphenol content using a method developed in our laboratory. These results showed that blood and tissues octylphenol concentrations were generally higher in female than male rats. Experiments done with rat liver microsomes confirmed that these differences were related to octylphenol metabolism. The results of the repeated exposure study indicate that there is no bioaccumulation of octylphenol at these exposure levels. A physiologically-based pharmacokinetic model for octylphenol was developed and validated using the data obtained in female and male rats. The model simulates adequately blood and tissues octylphenol concentrations following oral, intravenous or subcutaneous exposure. In conclusion, this study provided essential data on the toxicokinetics of octylphenol. These data are essential to predict the relationship between the internal and the external dose of octylphenol and will facilitate the risk assessment of octylphenol in humans.
|
27 |
Caractérisation de la toxicocinétique de l’octylphénol chez le rat en vue d’une meilleure analyse de risque toxicologique des perturbateurs endocriniensHamelin, Geneviève 04 1900 (has links)
Le p-tert-octylphénol est un produit présent dans l’environnement et issu de la dégradation des alkylphénols éthoxylés. Ce composé a la capacité de se lier au récepteur œstrogénique et d’exercer ainsi un léger effet œstrogénique. Les objectifs de cette étude étaient de 1) développer une méthode d'identification de l'octylphénol dans le sang et les tissus à l'aide de la chromatographie en phase gazeuse jumelée à la spectrométrie de masse, 2) caractériser la toxicocinétique sanguine et tissulaire de l’octylphénol chez le rat Sprague-Dawley mâle et femelle et 3) développer un modèle toxicocinétique à base physiologique permettant de décrire la cinétique sanguine et tissulaire de l’octylphénol inchangé. Pour ce faire, des rats mâle et femelle Sprague-Dawley ont reçu des doses uniques d’octylphénol par les voies intraveineuse, orale et sous-cutanée. Deux autres groupes ont reçu des doses répétées d'octylphénol par voie orale pour une durée de 35 jours consécutifs pour les femelles ou 60 jours pour les mâles. Les concentrations sanguines et tissulaires d’octylphénol ont été mesurées à différents moments après administration à partir d’une méthode d’analyse développée dans nos laboratoires dans le cadre de ce projet. Les expériences impliquant des administrations uniques ont montré que les concentrations sanguines et tissulaires d'octylphénol étaient en général plus élevées chez les femelles que chez les mâles. Des expériences réalisées avec des microsomes hépatiques ont confirmé que ces différences étaient vraisemblablement reliées au métabolisme de l'octylphénol. Les expériences impliquant des administrations répétées ont montré qu'il n'y avait pas d'accumulation d'octylphénol dans l'organisme aux doses étudiées. Les résultats obtenus expérimentalement ont servi à développer et valider un modèle toxicocinétique à base physiologique. Ce modèle a permis de simuler adéquatement les concentrations sanguines et tissulaires d'octylphénol suite à des expositions intraveineuses, orales et sous-cutanées. En conclusion, cette étude a fourni des données essentielles sur la toxicocinétique de l'octylphénol. Ces données sont nécessaires pour établir la relation entre la dose externe et la dose interne et vont contribuer à une meilleure évaluation des risques liés à l'octylphénol. / p-tert-Octylphenol is a degradation product of alkylphenol ethoxylates that can be found in the environment. It has been reported to act as a weak estrogenic compound by binding to the estrogen receptor. This study was undertaken to 1) develop a sensitive method for the determination of octylphenol in blood and various tissues using gas chromatography coupled with detection by mass spectrometry, 2) characterize the blood and tissues toxicokinetics of octylphenol in male and female Sprague-Dawley rats and 3) develop a physiologically-based toxicokinetic model for octylphenol that can describe/predict unchanged blood and tissues octylphenol concentrations in rats. Male and female Sprague-Dawley rats were given a single dose of octylphenol either by oral gavage, intravenous injection or subcutaneous injection. In a repeated dosing experiment, rats were given octylphenol (oral) daily for 35 days (female) or 60 days (male). Blood and tissue samples were collected at various time following the onset of exposure and analyzed for octylphenol content using a method developed in our laboratory. These results showed that blood and tissues octylphenol concentrations were generally higher in female than male rats. Experiments done with rat liver microsomes confirmed that these differences were related to octylphenol metabolism. The results of the repeated exposure study indicate that there is no bioaccumulation of octylphenol at these exposure levels. A physiologically-based pharmacokinetic model for octylphenol was developed and validated using the data obtained in female and male rats. The model simulates adequately blood and tissues octylphenol concentrations following oral, intravenous or subcutaneous exposure. In conclusion, this study provided essential data on the toxicokinetics of octylphenol. These data are essential to predict the relationship between the internal and the external dose of octylphenol and will facilitate the risk assessment of octylphenol in humans.
|
28 |
Die Wirkung der Fraktionen des Extraktes Cimicifuga racemosa BNO 1055 auf die Brustdrüse ovarektomierter Sprague-Dawley-Ratten / The effect of the fractions of Cimicifuga racemosa BNO 1055 extract on the mammary gland of ovariectomized sprague dawley ratsKübler, Jessica Viola 17 January 2018 (has links)
No description available.
|
29 |
Der Einfluss des Steroidhormons β-Ecdyson auf die Skelett- und Herzmuskulatur von weiblichen, ovarektomierten Sprague-Dawley-Ratten / The influence of the steroid-hormons ecdysone at the skeletal and heart muscle of female ovx Sprage-Dawley-RatsVolkert, Matthias 04 March 2013 (has links)
No description available.
|
Page generated in 0.0561 seconds